Sign In
Buy ARDX
$6.18
-0.190 (-2.98%)
At Close: Jun 23, 2026
Ardelyx (NASDAQ:ARDX) Reaches New 52-Week High – Time to Buy?
04:24am, Friday, 09'th Jan 2026
Ardelyx, Inc. (NASDAQ: ARDX - Get Free Report) hit a new 52-week high on Friday. The stock traded as high as $7.10 and last traded at $7.00, with a volume of 15572522 shares changing hands. The stock
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
08:30am, Thursday, 08'th Jan 2026
Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue 1
Wall Street Analysts See a 92.12% Upside in Ardelyx (ARDX): Can the Stock Really Move This High?
10:55am, Tuesday, 06'th Jan 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 92.1% in Ardelyx (ARDX). While the effectiveness of this highly sought-after metric is questionable, the positi
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last?
09:25am, Monday, 05'th Jan 2026
Ardelyx (ARDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Squarepoint Ops LLC Takes $708,000 Position in Ardelyx, Inc. $ARDX
05:08am, Wednesday, 24'th Dec 2025
Squarepoint Ops LLC acquired a new position in shares of Ardelyx, Inc. (NASDAQ: ARDX) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
Ardelyx, Inc. (NASDAQ:ARDX) Given Consensus Recommendation of “Moderate Buy” by Analysts
01:32am, Monday, 22'nd Dec 2025
Ardelyx, Inc. (NASDAQ: ARDX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the stock, MarketBeat reports. One research analyst
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of “Moderate Buy” from Brokerages
02:12am, Thursday, 27'th Nov 2025
Shares of Ardelyx, Inc. (NASDAQ: ARDX - Get Free Report) have earned an average rating of "Moderate Buy" from the thirteen brokerages that are covering the stock, Marketbeat.com reports. One equities
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
08:00am, Wednesday, 05'th Nov 2025
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
Ardelyx: Impressive Q3 Record Growth - Why I Buy
04:24am, Wednesday, 05'th Nov 2025
Ardelyx (ARDX) is rated BUY, driven by strong Q3 2025 results, led by IBSRELA's explosive growth and resilient pipeline. IBSRELA revenue surged 92% YoY, offsetting XPHOZAH's Medicare-related decline;
Ardelyx: A Long Overdue Rally
03:32pm, Tuesday, 04'th Nov 2025
Ardelyx shares surged on Friday after strong Q3 results and positive guidance, validating patience during previous setbacks. The company demonstrated resilience, with recent financial performance supp
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
Ardelyx Target of Unusually Large Options Trading (NASDAQ:ARDX)
04:46am, Sunday, 02'nd Nov 2025
Ardelyx, Inc. (NASDAQ: ARDX - Get Free Report) saw some unusual options trading activity on Friday. Stock investors bought 4,907 call options on the stock. This represents an increase of approximately
10,151 Shares in Ardelyx, Inc. $ARDX Acquired by Brighton Jones LLC
04:07am, Sunday, 02'nd Nov 2025
Brighton Jones LLC bought a new position in shares of Ardelyx, Inc. (NASDAQ: ARDX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The i
Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript
11:06pm, Thursday, 30'th Oct 2025
Ardelyx, Inc. ( ARDX ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Caitlin Lowie - Vice President of Corporate Communications & Investor Relations Michael Raab - President,
